- Apr 19
Study successfully mimics complex neuroblastoma vasculature on a chip to explore treatments
One of the research focal points of Dr. Josep Samitier's group (Nanobioengineering Group of IBEC), led by Dr. Aránzazu Villasante, is the...
- Apr 10
Change in MYCN-driven cell state opens therapeutic window in high-risk neuroblastoma
A switch between cell states within MYCN-amplified neuroblastoma promotes KDM4, inhibition of which shows promising anticancer potential....
- Mar 28
A team effort delivers a new tool for fighting neuroblastoma
Families of paediatric cancer patients have helped move a pioneering treatment for neuroblastoma from the lab to the clinic. Could this...
- Mar 26
Study identifies patients who benefit most from dinutuximab-based immunotherapy
Using data from a randomized phase III clinical trial of neuroblastoma patients (treated with or without immunotherapy) performed by the...
- Mar 7
Combining CAR-T cells and inhibitor drugs for high-risk neuroblastoma
Roberto Chiarle, MD, at Boston Children's Hospital and his colleagues now report a way to make CAR-T cell therapy work better in...
- Mar 5
Universal, essential biomarker identified for childhood neuroblastoma
Researchers have newly identified a universal, essential biomarker for the childhood cancer neuroblastoma – and a potential new target...
- Feb 20
New Resource for Selecting Best Treatment Path for Young Children with Cancerous Tumors Published by NCCN
New NCCN Guidelines for Neuroblastoma address the importance and impact of risk stratification for treating one of the more common types...
- Feb 6
Cancer researcher 'beefing up' natural killer cells to stop cancer
A UCF cancer researcher is discovering ways that the body's own natural killer (NK) cells can be energized to fight deadly pediatric...